Atossa Therapeutics, Inc. (ATOS)
2.42
0.00 (0.00%)
USD |
NASDAQ |
Sep 17, 16:00
2.37
-0.05
(-2.07%)
After-Hours: 18:16
Atossa Therapeutics Price to Book Value : 0.9001 for Sept. 17, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 16, 2026 | 0.9001 |
| September 15, 2026 | 0.8815 |
| September 14, 2026 | 0.9224 |
| September 11, 2026 | 0.9336 |
| September 10, 2026 | 0.8704 |
| September 09, 2026 | 0.8927 |
| September 08, 2026 | 0.9354 |
| September 04, 2026 | 0.9373 |
| September 03, 2026 | 0.941 |
| September 02, 2026 | 0.915 |
| September 01, 2026 | 0.9001 |
| August 31, 2026 | 0.9299 |
| August 28, 2026 | 0.9596 |
| August 27, 2026 | 0.9819 |
| August 26, 2026 | 0.9857 |
| August 25, 2026 | 0.9968 |
| August 24, 2026 | 0.9819 |
| August 21, 2026 | 0.9447 |
| August 20, 2026 | 0.9633 |
| August 19, 2026 | 0.9819 |
| August 18, 2026 | 0.9633 |
| August 17, 2026 | 1.038 |
| August 14, 2026 | 0.9671 |
| August 13, 2026 | 0.9522 |
| August 12, 2026 | 0.8741 |
| Date | Value |
|---|---|
| August 11, 2026 | 0.8778 |
| August 10, 2026 | 0.8815 |
| August 07, 2026 | 0.8778 |
| August 06, 2026 | 0.9001 |
| August 05, 2026 | 0.8889 |
| August 04, 2026 | 0.8592 |
| August 03, 2026 | 0.8071 |
| July 31, 2026 | 0.7699 |
| July 30, 2026 | 0.8146 |
| July 29, 2026 | 0.8592 |
| July 28, 2026 | 0.8982 |
| July 27, 2026 | 0.8778 |
| July 24, 2026 | 0.8536 |
| July 23, 2026 | 0.8964 |
| July 22, 2026 | 0.9038 |
| July 21, 2026 | 0.8927 |
| July 20, 2026 | 0.9261 |
| July 17, 2026 | 0.9261 |
| July 16, 2026 | 0.8889 |
| July 15, 2026 | 0.9075 |
| July 14, 2026 | 0.8406 |
| July 13, 2026 | 0.8927 |
| July 10, 2026 | 0.8815 |
| July 09, 2026 | 0.8778 |
| July 08, 2026 | 0.9113 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Immix Biopharma, Inc. | 3.981 |
| ACADIA Pharmaceuticals, Inc. | 3.616 |
| Alnylam Pharmaceuticals, Inc. | 24.25 |
| Anika Therapeutics, Inc. | 2.046 |
| Savara, Inc. | 7.742 |
Price to Book Value Related Metrics
| PEG Ratio | -0.0041 |
| Price | 2.42 |
| Earnings Yield | -179.5% |
| Market Cap | 24.15M |
| PEGY Ratio | -0.0041 |